Ads by Google
The New York Times examined access to health care for undocumented immigrant farm workers in US, who often do not have health coverage.
Atrium Medical Corporation is initiating a voluntary and precautionary recall of selected lots of HYDRAGLIDE Brand Heparin-Coated Thoracic Drainage Catheters. Limited lots of Atrium heparin-coated Hydraglide Thoracic Catheters were manufactured with heparin found to have been contaminated with oversulfated chondroitin sulfate (OSCS).
While pay-for-performance programs may succeed in improving clinical outcomes and increasing physician income, they also change the nature of patient consultations and the way doctors and nurses work together.
FDA approved a new formulation of the genetically engineered version of Factor VIIa, a plasma protein essential for the clotting of blood. The new formulation allows the product to be stored at room temperature (up to 81 degrees Fahrenheit) for up to two years.
California fertility specialists are edging away from a traditional and well-known infertility treatment -- artificial insemination -- saying newer and improving in vitro fertilization technology tends to cost less and work far better in the long run, ultimately saving patients time, money and heartache.
Pioneer Surgical Technology announced the successful human implantation of its next generation cervical total disc replacement, NuNec Cervical Arthroplasty Device.
Nearly 28 percent of all visits to the pediatric emergency department could have been replaced with a more cost-effective Internet doctor's 'visit.'
Researchers have begun testing new approaches to transplanting clusters of insulin-producing islets in adults with difficult-to-control type 1 diabetes.
Scientists are developing a new way of quickly creating human antibodies - called monoclonal antibodies.
University of Iowa researchers have succeeded in wiping out established biofilms of Staphylococcus aureus (staph) by hijacking one of the bacteria's own regulatory systems. Although the discovery is not ready for clinical application, the findings offer insight into a dispersal mechanism for staph biofilms and might help identify therapeutic targets.
Researchers have succeeded in inducing stem cells grown from mouse skin cells to differentiate into functioning cardiovascular and blood cells.
Scientists report the discovery of five single letter variants at five different sites in the human genome that impact bone mineral density and predispose to fracturing of bones.
Variation in several genes that are associated with metabolic and inflammatory regulation also have significant effects on C-reactive protein (CRP) levels.
Smith & Nephew's Endoscopy Division launched the FOOTPRINT PK Suture Anchor, a system used to attach rotator cuff tissue to bone in the shoulder.
Researchers have made a major advance in understanding how bacteria divide.
Researchers have found menstrual blood to be a potentially unlimited, noncontroversial, easily collectable, and inexpensive source for of stem cells for use in regenerative medicine.
Health officials in the U.S. appear to be at loggerheads with Chinese officials over the contamination of the blood-thinning drug Heparin.
Government is taking action to protect the health of Canadians and the environment from another chemical of concern.
NTOCC Advisory Task Force authorized the release of recently developed tools for helping healthcare professionals and organizations address problems inherent in transitioning patients from one level of care to another.
USP Convention announces that it is working with FDA to develop more sensitive methods for detecting contaminants recently found in the widely used blood-thinning drug heparin.
Cryo-Cell International announced results of a study published this month in Cell Transplantation showing that stem cells found in menstrual blood proliferate rapidly and have significant potential to develop into multiple cell types.
Researchers have identified a gene that is responsible for the division and movement of marrow-derived, blood-forming stem cells, a finding that could have major implications for the future of bone marrow and blood cell transplantation.
Botaneco launches second generation oleosome product, Hydresia G2, at the In-Cosmetics 2008 exposition in Amsterdam.
- « first
- ‹ previous
- next ›
- last »